A084

LabGenomics Co., Ltd. Stock Price

KOSDAQ:A084650 Community·₩171.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A084650 Share Price Performance

₩2,310.00
-765.00 (-24.88%)
₩2,310.00
-765.00 (-24.88%)
Price ₩2,310.00

A084650 Community Narratives

There are no narratives available yet.

LabGenomics Co., Ltd. Key Details

₩88.0b

Revenue

₩57.2b

Cost of Revenue

₩30.8b

Gross Profit

₩65.8b

Other Expenses

-₩35.0b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-471.99
Gross Margin
34.97%
Net Profit Margin
-39.83%
Debt/Equity Ratio
24.5%

LabGenomics Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

1 Risk
0 Rewards

About A084650

Founded
2002
Employees
143
CEO
Sung Chin
WebsiteView website
www.labgenomics.co.kr

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

South Korean Market Performance

  • 7 Days: 1.6%
  • 3 Months: 13.5%
  • 1 Year: 35.3%
  • Year to Date: 47.0%
In the last week, the market has been flat. More promisingly, the market is up 33% over the past year. Earnings are forecast to grow by 24% annually. Market details ›